Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX)

CUSIP: 15117B202

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,629,115
Total 13F shares
3,949,694
Share change
+44,070
Total reported value
$6,557,892
Put/Call ratio
33%
Price per share
$1.66
Number of holders
32
Value change
+$7,227
Number of buys
11
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) as of Q1 2020

As of 31 Mar 2020, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,949,694 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Cresset Asset Management, LLC, TSP Capital Management Group, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and CREDIT SUISSE AG/. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.